Aubree Gordon, PhD, MPH

• PhD, University of California, Berkeley, 2009
• MPH, University of California, Berkeley, 2005
• MA, University of California, Berkeley 2002
• BS University of North Carolina at Chapel Hill, 1998

Research Interests:
Infectious disease, global health, respiratory viruses, influenza, SARS-CoV-2, arboviral diseases

Research Projects:
Dr. Gordon's ongoing studies include a household cohort study in Managua, Nicaragua that began in May of 2017 and was recently extended into 2028. The study consists of a family cohort with an embedded transmission study to investigate both influenza and SARS-CoV-2.

The Nicaraguan Pediatric Influenza Cohort Study, which began in January 2011, is a community-based prospective study of ~1,700 children from birth through 14 years of age in. Design features of this study will allow it to provide information about repeat natural influenza infections, the development of immunity, and immune imprinting.

In collaboration with Michigan Medicine, Dr. Gordon co-leads the Immunity-associated with SARS-CoV-2 (IASO) Cohort Study, a prospective cohort study of ~3500 adults in Michigan that began in October 2020. IASO is generating important data on SARS-CoV-2 and has supplied critical serum samples to the SARS-CoV-2 Variant Evolution (SAVE) working group.

Dr. Gordon also collaborates on a number of arboviral studies including studies in Managua, Nicaragua, Sri Lanka, and Ecuador.

Maier HE, Balmaseda A, Saborio S, Ojeda S, Barilla C, Sanchez N, Lopez R, Plazaola M, Cerpas C, van Bakel H, Kubale J, Harris E, Kuan G, Gordon A. Protection Associated with Previous SARS-CoV-2 Infection in Nicaragua. New England Journal Medicine 2022 Aug 11;387(6):568-570. doi: 10.1056/NEJMc2203985. Epub 2022 Jul 20.

Kubale, J., Balmaseda, A., Frutos, AF, Sanchez, N, Plazaola, M, Ojeda, S, Saborio, S, Lopez, R, Barilla, C, Vasquez, G, Moreira, H, Gajewski, A, Campredon, L, Maier, H, Chowdhury, M, Cerpas, C, Harris, E, Kuan, G, Gordon, A. Association of SARS-CoV-2 Seropositivity and Symptomatic Reinfection in Children in Nicaragua. 2022 Jun 1;5(6):e2218794. doi: 10.1001/jamanetworkopen.2022.18794.   

Maier, HE, Kuan, G, Gresh, L, Chowell, G, Bakker, K, Lopez, R, Sanchez, N, Lopez, B, Schiller, A, Ojeda, S, Harris, E, Balmaseda, A, and Gordon, A. The Nicaraguan Pediatric Influenza Cohort Study, 2011-2019: influenza incidence, seasonality, and transmission. Clinical Infectious Diseases 2022 May 26; https://doi.org/10.1093/cid/ciac420. 

Wraith, S, Balmaseda, A, Bustos Carrillo, FA, Kuan, G, Huddleston, J, Kubale, J, Lopez, R, Ojeda, S, Schiller, A, Lopez, B, Sanchez, N, Webby, R, Nelson, MI, Harris, E, Gordon, A. Homotypic protection against influenza in a pediatric cohort in Managua, Nicaragua. Nature Communications 2022 Mar 4;13(1):1190. doi: 10.1038/s41467-022-28858-9. 

Ng, S., Nachbagauer, R., Balmaseda, A., Stadlbauer, D., Ojeda, S., Patel, M., Rajabhathor, A., Lopez, R., Guglia, A.F., Sanchez, N., Amanat, F., Gresh, L., Kuan, G., Krammer, F., and Gordon, A. Novel correlates of protection against influenza A(H1N1)pdm infection. Nature Medicine 2019 Jun;25(6):962-967.

Gordon, A., Gresh, L., Ojeda, S., Katzelnick, L.A., Sanchez, N., Karla Gonzalez, K., Lopez, B., Nunez, A., Josefina Coloma, J., Burger-Calderon, R., Kuan, G., Balmaseda, A., and Harris, E. Prior dengue virus infection protects against Zika in a pediatric cohort in Nicaragua. PLOS Med. 2019 Jan 22;16(1):e1002726. doi: 10.1371/journal.pmed.1002726. eCollection 2019 Jan.

Email: [email protected]

Office: 734-763-3580

Address:5622 SPH I
1415 Washington Heights
Ann Arbor, MI 48109

For media inquiries: [email protected]